Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

256 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.
Leuschner C, Enright FM, Gawronska-Kozak B, Hansel W. Leuschner C, et al. Among authors: hansel w. Prostate. 2003 Sep 1;56(4):239-49. doi: 10.1002/pros.10259. Prostate. 2003. PMID: 12858351
Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates.
Hansel W, Leuschner C, GawroĊ„ska B, Enright F. Hansel W, et al. Reprod Biol. 2001 Jul;1(1):20-32. Reprod Biol. 2001. PMID: 14666172
Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors.
Leuschner C, Enright FM, Melrose PA, Hansel W. Leuschner C, et al. Among authors: hansel w. Prostate. 2001 Feb 1;46(2):116-25. doi: 10.1002/1097-0045(20010201)46:2<116::aid-pros1015>3.0.co;2-b. Prostate. 2001. PMID: 11170139
Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.
Zaleska M, Bodek G, Jana B, Hansel W, Ziecik AJ. Zaleska M, et al. Among authors: hansel w. Exp Clin Endocrinol Diabetes. 2003 May;111(3):146-53. doi: 10.1055/s-2003-39787. Exp Clin Endocrinol Diabetes. 2003. PMID: 12784188
[DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.
Aggarwal S, Ndinguri MW, Solipuram R, Wakamatsu N, Hammer RP, Ingram D, Hansel W. Aggarwal S, et al. Among authors: hansel w. Int J Cancer. 2011 Oct 1;129(7):1611-23. doi: 10.1002/ijc.26132. Epub 2011 Jul 20. Int J Cancer. 2011. PMID: 21484797 Free PMC article.
Effect of media substitutes on bovine granulosa cell function and proliferation during in vitro culture.
Broussard JR, Thibodeaux JK, Myers MW, Roussel JD, Hansel W, Godke RA. Broussard JR, et al. Among authors: hansel w. J Anim Sci. 1995 Nov;73(11):3287-93. doi: 10.2527/1995.73113287x. J Anim Sci. 1995. PMID: 8586586
Membrane disrupting lytic peptides for cancer treatments.
Leuschner C, Hansel W. Leuschner C, et al. Among authors: hansel w. Curr Pharm Des. 2004;10(19):2299-310. doi: 10.2174/1381612043383971. Curr Pharm Des. 2004. PMID: 15279610 Review.
Targeting breast and prostate cancers through their hormone receptors.
Leuschner C, Hansel W. Leuschner C, et al. Among authors: hansel w. Biol Reprod. 2005 Nov;73(5):860-5. doi: 10.1095/biolreprod.105.043471. Epub 2005 Jul 20. Biol Reprod. 2005. PMID: 16033998 Review.
Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases.
Hansel W, Leuschner C, Enright F. Hansel W, et al. Mol Cell Endocrinol. 2007 Apr 15;269(1-2):26-33. doi: 10.1016/j.mce.2006.06.017. Epub 2007 Feb 15. Mol Cell Endocrinol. 2007. PMID: 17382461 Review.
Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.
Hansel W, Enright F, Leuschner C. Hansel W, et al. Mol Cell Endocrinol. 2007 Jan 2;260-262:183-9. doi: 10.1016/j.mce.2005.12.056. Epub 2006 Nov 13. Mol Cell Endocrinol. 2007. PMID: 17101210
256 results
Jump to page
Feedback